scholarly article | Q13442814 |
P2093 | author name string | Jeffrey Holzbeierlein | |
J Brantley Thrasher | |||
Dev Karan | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
inflammation | Q101991 | ||
macrophage | Q184204 | ||
P304 | page(s) | 2-5 | |
P577 | publication date | 2009-01-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer | |
P478 | volume | 69 |
Q38780449 | A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT). |
Q48136110 | Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15. |
Q42974266 | Anti-androgen resistance in prostate cancer cells chronically induced by interleukin-1β. |
Q64099112 | Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis |
Q37252687 | Association and regulation of protein factors of field effect in prostate tissues |
Q35076351 | Bevacizumab in metastatic breast cancer: when may it be used? |
Q39036378 | Cancer and inflammation |
Q83945607 | Diagnostic issues of prostate biopsies. Case 5. Foamy cell carcinoma, associated with xanthomatous inflammation |
Q34099900 | Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer |
Q41093240 | Elevated serum growth differentiation factor 15 levels are associated with thyroid nodules in type 2 diabetes aged over 60 years |
Q35242266 | Gene expression signatures differ with extent of atherosclerosis in monkey iliac artery |
Q33586722 | Genomic profiling of tumor initiating prostatospheres |
Q37896086 | Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside |
Q48176713 | Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. |
Q36076068 | Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer |
Q47839645 | Linking Race, Cancer Outcomes, and Tissue Repair. |
Q36300793 | Linking obesogenic dysregulation to prostate cancer progression |
Q33882542 | Macrophage inhibitory cytokine-1 regulates melanoma vascular development |
Q24620497 | Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway |
Q38019709 | Promiscuity and specificity in BMP receptor activation |
Q33642321 | Prostate cancer and inflammation: the evidence |
Q35175108 | Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue |
Q82719031 | Regulating inflammation: ADAM8 – a new player in the game |
Q47129121 | Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
Q89601774 | Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury |
Q55302098 | Specific expression pattern of tissue cytokines analyzed through the Surface Acoustic Wave technique is associated with age-related spontaneous benign prostatic hyperplasia in rats. |
Q43199989 | Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents. |
Q57105625 | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer |
Q26750847 | The impact of obesity towards prostate diseases |
Q38115886 | The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1 |
Q38211077 | The role of inflammation in prostate cancer |
Q33548826 | The significance of chronic prostatitis for the etiopathology of prostate cancer |
Q53099014 | The value of macrophage inhibitory cytokine-1 level in differentiating benign from malignant solitary pulmonary nodules |
Q91144968 | Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15 |
Search more.